Trademark: 87117832
Word
MEDVU
Status
Dead
Status Code
606
Status Date
Monday, April 8, 2019
Serial Number
87117832
Mark Type
4000
Filing Date
Wednesday, July 27, 2016
Published for Opposition
Tuesday, July 11, 2017
Abandoned Date
Monday, April 8, 2019

Trademark Owner History
SIGHTLINE INNOVATION INC. - Owner At Publication

Classifications
9 Computer software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; computer software for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, genomic data, and environmental factors, for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, medical diagnostics, molecular medicine, precision medicine, and structural and functional analysis of genomes; computer software for use in the detection, identification, analysis, and classification of pathogens and toxins in a biological sample; computer software for the analysis of genomic data for use in tracking variation and mutation of pathogens; computer software featuring machine learning and deep learning algorithms for use in medical diagnostic testing, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, genetic testing for medical purposes, detection of pathogens and toxins in a biological sample, and molecular medicine, namely research, diagnosis and treatment of medical conditions on the basis of molecular mechanisms of disease; computer software for determining and predicting patterns in data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; computer software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for determining and predicting patterns in said data
42 Structural and functional analysis of genomes; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; providing software as a service (SaaS) for enabling others to access software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) for enabling others to access software for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, genomic data, and environmental factors, for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, medical diagnostics, molecular medicine, namely research, diagnosis and treatment of medical conditions on the basis of molecular mechanisms of disease, precision medicine, namely the customization and personalization of therapies and medical treatment practices for individual patients, and structural and functional analysis of genomes; providing software as a service (SaaS) for enabling others to access software for use in the detection, identification, analysis, and classification of pathogens and toxins in a biological sample; providing software as a service (SaaS) for enabling others to access software for the analysis of genomic data for use in tracking variation and mutation of pathogens; providing software as a service (SaaS) for enabling others to access and use machine learning and deep learning algorithms for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, genetic testing for medical purposes, detection of pathogens and toxins in a biological sample, and molecular medicine, namely research, diagnosis and treatment of medical conditions on the basis of molecular mechanisms of disease; providing software as a service (SaaS) for enabling others to upload and manage data for determining and predicting patterns in the data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factors; providing software as a service (SaaS) for enabling others to upload and manage data for the training of data models by machine learning and deep learning processes
44 Medical diagnostic services in the fields of infectious diseases, rheumatological diseases, cardiovascular diseases, respiratory diseases, endocrine diseases, neurological diseases, nephrological diseases, urological diseases, gynaecological diseases, obstetrical diseases, hematological diseases, gastroenterological diseases, neuropsychiatry, and oncology; Medical screening; Medical testing services in the fields of infectious diseases, rheumatological diseases, cardiovascular diseases, respiratory diseases, endocrine diseases, neurological diseases, nephrological diseases, urological diseases, gynaecological diseases, obstetrical diseases, hematological diseases, gastroenterological diseases, neuropsychiatry, and oncology; DNA screening for medical purposes; genetic testing for medical purposes

Trademark Events
Apr 8, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 8, 2019
Abandonment - No Use Statement Filed
Sep 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 5, 2018
Extension 2 Granted
Sep 5, 2018
Extension 2 Filed
Sep 5, 2018
Teas Extension Received
Mar 1, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 27, 2018
Extension 1 Granted
Feb 27, 2018
Extension 1 Filed
Feb 27, 2018
Teas Extension Received
Sep 5, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 11, 2017
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2017
Published For Opposition
Jun 21, 2017
Notification Of Notice Of Publication E-Mailed
May 30, 2017
Approved For Pub - Principal Register
May 26, 2017
Examiner's Amendment Entered
May 26, 2017
Notification Of Examiners Amendment E-Mailed
May 26, 2017
Examiners Amendment E-Mailed
May 26, 2017
Examiners Amendment -Written
May 9, 2017
Teas/Email Correspondence Entered
May 9, 2017
Correspondence Received In Law Office
May 9, 2017
Teas Response To Office Action Received
Nov 9, 2016
Notification Of Non-Final Action E-Mailed
Nov 9, 2016
Non-Final Action E-Mailed
Nov 9, 2016
Non-Final Action Written
Nov 7, 2016
Assigned To Examiner
Aug 1, 2016
New Application Office Supplied Data Entered In Tram
Jul 30, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24